产品封面图
文献支持

Recombinant HIV-1 Envelope con

jugated to HIV-2 gp36
收藏
  • ¥2700 - 17000
  • Prospecbio
  • 以色列
  • hiv-131
  • 2026年01月30日
    avatar
  • 企业认证

    点击 QQ 联系

    • 详细信息
    • 文献和实验
    • 技术资料
    • 保存条件

      for future use below -18°C

    • 保质期

      See instructions

    • 英文名

      HIV-1,2

    • 库存

      常规产品有备货

    • 供应商

      上海经科化学科技有限公司

    • CAS号

    • 规格

      100ug/0.5mg/1mg

    规格:100ug产品价格:¥2700.0
    规格:0.5mg产品价格:¥10500.0
    规格:1mg产品价格:¥17000.0

    产品细节图片1

    CATALOGUE NUMBER

    HIV-131

    INTRODUCTION

    HIV-1 and HIV-2 appear to package their RNA differently. HIV-1 binds to any appropriate RNA whereas HIV-2 preferentially binds to mRNA which creates the Gag protein itself. This means that HIV-1 is better able to mutate. HIV-2 is transmitted in the same ways as HIV-1: Through exposure to bodily fluids such as blood, semen, tears and vaginal fluids.
    Immunodeficiency develops more slowly with HIV-2.
    HIV-2 is less infectious in the early stages of the virus than with HIV-1.
    The infectiousness of HIV-2 increases as the virus progresses.Major differences include reduced pathogenicity of HIV-2 relative to HIV-1, enhanced immune control of HIV-2 infection and often some degree of CD4-independence. Despite considerable sequence and phenotypic differences between HIV-1 and 2 envelopes, structurally they are quite similar. Both membrane-anchored proteins eventually form the 6-helix bundles from the N-terminal and C-terminal regions of the ectodomain, which is common to many viral and cellular fusion proteins and which seems to drive fusion.
    HIV-1 gp41 helical regions can form more stable 6-helix bundles than HIV-2 gp41 helical regions however HIV-2 fusion occurs at a lower threshold temperature (25°C), does not require Ca2+ in the medium, is insensitive to treatment of target cells with cytochalasin B, and is not affected by target membrane glycosphingolipid composition.

    DESCRIPTION

    HIV-1,2 recombinant- E.Coli derived recombinant 27 kDa protein contains the C- terminus of gp120 and most of gp41. The protein is conjugated to a 23 amino acids synthetic peptide derived from gp36 of HIV-2.

    SOURCE

    Escherichia Coli.

    PHYSICAL APPEARANCE

    Sterile filtered colorless clear solution.

    FORMULATION

    100mM NaPO4, pH 6 and 0.05% SDS.

    PURITY

    Greater than 90.0% as determined by SDS-PAGE.

    STABILITY

    HIV-1,2 although stable at 4°C for 1 week, should be stored below -18°C.
    Please prevent freeze thaw cycles.

    SPECIFICITY

    Immunoreactive with all sera of HIV-1, HIV type O & HIV-2 infected individuals.

    APPLICATIONS

    HIV-1,2 antigen is suitable for ELISA and Western blots, excellent antigen for early detection of HIV seroconvertors with minimal specificity problems.

    SAFETY DATA SHEET

    SDS

    USAGE

    ProSpec's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    图标文献和实验
    该产品被引用文献

    HIV-1,2 recombinant- E.Coli derived recombinant 27 kDa protein contains the C- terminus of gp120 and most of gp41. The protein is conjugated to a 23 amino acids synthetic peptide derived from gp36 of HIV-2.

    相关实验

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    ¥6218.10
    北京孚博生物科技有限公司
    2025年07月16日询价
    ¥2919
    爱必信(上海)生物科技有限公司
    2025年05月26日询价
    ¥2919
    上海优宁维生物科技股份有限公司
    2025年08月27日询价
    ¥2700
    上海经科化学科技有限公司
    2026年02月01日询价
    $150
    安诺伦(北京)生物科技有限公司
    2023年10月25日询价
    文献支持
    Recombinant HIV-1 Envelope conjugated to HIV-2 gp36
    ¥2700 - 17000